JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Adverum Biotechnologies Inc

Closed

SectorHealthcare

4.05 -2.17

Overview

Share price change

24h

Current

Min

4.02

Max

4.22

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+170.27% upside

Dividends

By Dow Jones

Next Earnings

31 Oct 2025

News Sentiment

By Acuity

81%

19%

344 / 371 Healthcare

Adverum Biotechnologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Oct 2025, 13:04 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Agrees to Acquire Adverum Biotechnologies

24 Oct 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

24 Oct 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

24 Oct 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

24 Oct 2025, 12:30 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Adverum Biotechnologies >LLY ADVM

Peer Comparison

Price change

Adverum Biotechnologies Inc Forecast

Price Target

By TipRanks

170.27% upside

12 Months Forecast

Average 11 USD  170.27%

High 30 USD

Low 3 USD

Based on 6 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

3

Buy

3

Hold

0

Sell

Sentiment

By Acuity

344 / 371 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

help-icon Live chat